United States Veterinary Endocrinology Market Size, Share, and COVID-19 Impact Analysis, By Animal Type (Dogs, Cats, and Others), By Application (Pancreatic Disorders, and Others), and United States Veterinary Endocrinology Market Insights, Industry Trend, Forecasts to 2035

United States Veterinary Endocrinology Market Insights Forecasts to 2035

• The United States Veterinary Endocrinology Market Size Was Estimated at USD 116.18 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.25% from 2025 to 2035
• The United States Veterinary Endocrinology Market Size is Expected to Reach USD 226.25 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United States veterinary endocrinology market is anticipated to reach USD 226.25 Million by 2035, growing at a CAGR of 6.25% from 2025 to 2035. The U.S. veterinary endocrinology market grows due to rising endocrine disorders like diabetes and hypothyroidism in pets. Increased pet humanization boosts demand for specialized care. Advances in diagnostic technologies and treatments improve management. Expanding pet insurance also enhances access to veterinary endocrinology services, collectively driving market growth across the country.

Market Overview

The U.S. veterinary endocrinology market defines the diagnosis and treatment of hormone-related health issues in animals, like diabetes and thyroid problems. It includes specialized care and products that help keep pets and other animals healthy, improving their overall well-being and quality of life. The market is expanding due to the increasing prevalence of these conditions among pets, particularly dogs and cats. Factors such as the humanization of pets, advancements in diagnostic technologies, and the availability of specialized treatments contribute to the growth of this market. The market’s strengths come from cutting-edge diagnostic tools, more people welcoming pets into their homes, and the way pets are now seen as family members. The market offers opportunities in expanding advanced diagnostic tools and personalized treatment options for hormonal disorders in pets. Government initiatives have helped speed up the approval and availability of medications for animals, promoting the development and accessibility of treatments for endocrine disorders in pets.

Report Coverage

This research report categorizes the market for the United States veterinary endocrinology market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States veterinary endocrinology market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States veterinary endocrinology market.

Driving Factors

The rising prevalence of hormonal conditions like diabetes, hypothyroidism, and Cushing’s disease in pets is a key factor fueling market growth.  As more people treat their pets like family, there’s a greater demand for specialized healthcare services. Advances in diagnostic tools and treatment options have made it easier to detect and manage these conditions effectively. Additionally, greater awareness among pet owners regarding the importance of early detection and preventive healthcare is contributing to the market’s expansion. The increasing availability of pet insurance also makes advanced treatments more affordable and accessible. Together, these factors encourage veterinarians to adopt cutting-edge endocrinology solutions, further driving the market forward as pet health becomes a higher priority for owners across the U.S.

Restraining Factors

The high treatment costs and limited awareness among some pet owners about endocrine disorders. Additionally, the complexity of diagnosing hormonal diseases in animals can delay care. These factors, along with limited availability of specialized veterinary endocrinologists in certain regions, may restrict market growth.

Market Segmentation

The United States veterinary endocrinology market share is classified into animal type and application.

• The dogs segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States veterinary endocrinology market is segmented by animal type into dogs, cats, and others. Among these, the dogs segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to dogs are the most common pets diagnosed with endocrine disorders like diabetes and hypothyroidism. Their larger population, combined with increased pet care awareness and willingness to invest in specialized treatments, drives higher demand for veterinary endocrinology services in dogs.

• The pancreatic disorders segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States veterinary endocrinology market is segmented by application into pancreatic disorders and others. Among these, the pancreatic disorders segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to conditions like diabetes mellitus are highly prevalent in pets. The complexity and chronic nature of these diseases require ongoing diagnosis and treatment, driving demand for specialized veterinary endocrinology services focused on pancreatic health.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States veterinary endocrinology market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Dechra Pharmaceuticals PLC
• Randox Laboratories, Ltd.
• Antech Diagnostics, Inc.
• Ceva Animal Health Inc.
• IDEXX Laboratories, Inc.
• Virbac Corporation
• Stokes Pharmacy
• Merck & Co., Inc.
• Vetoquinol USA
• Covetrus, Inc.
• LLOYD, Inc.
• Zoetis, Inc.
• Mars, Inc.
• Others

Recent Developments:

• In July 2024, Invetx Inc., a pioneer in protein-based therapeutics for animal health, announced that it had agreed to be acquired by Dechra Pharmaceuticals Limited (Dechra), a global specialist veterinary pharmaceuticals business, for up to $520 million in total consideration on a cash-free and debt-free basis. The acquisition was subject to antitrust approval and other customary closing conditions.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the U.S., regional, and country levels from 2020 to 2035. Spherical Insights has segmented the USA veterinary endocrinology market based on the below-mentioned segments:

United States Veterinary Endocrinology Market, By Animal Type

• Dogs
• Cats
• Others

United States Veterinary Endocrinology Market, By Application

• Pancreatic Disorders
• Others